Ayman El Deeb – Cluster Head, Astellas Egypt
Ayman El Deeb, cluster head of Astellas Egypt, highlights how the Egyptian affiliate of Astellas has been performing since its establishment five years ago. He also discusses the need for…
Eva Pharma is one of the leading and fastest growing pharmaceutical manufacturers in the MENA region, with a 30%+ CAGR over the past five years. It is a branded generics powerhouse which also operates in OTC and food supplements. Eva Pharma has a portfolio of over 126 products; covering various therapeutic classes including Neurology, Psychiatry, Cardiovascular, Orthopedics, GIT, Pediatrics, Urology and Dermatology. The company has its own sales teams in many countries of the MENA region including Egypt, KSA, UAE, Bahrain, Qatar, Oman, Kuwait, Iraq, Lebanon, Yemen, Kenya, Libya & Ethiopia. Its distinctive state-of-the-art manufacturing facility in Cairo is approved by EMA, SFDA & GCC authorities allowing it to be a contract manufacturer for some of the leading companies in the globe. Eva Pharma is led by a distinctive team of professionals with a forward thinking philosophy, it continues to add local and international manufacturing facilities wherever opportunities arise and is growing strategically to ensure its high quality affordable products are available for all.
Contact
Armanious Group Tower, 9 El Sharekat Street, Opera – Abdeen, Cairo, Egypt
P.O. Box: 1002 & 845
Postal code: 11518
Ayman El Deeb, cluster head of Astellas Egypt, highlights how the Egyptian affiliate of Astellas has been performing since its establishment five years ago. He also discusses the need for…
On Tuesday, February 12th, Pharmaboardroom attended a breakfast event hosted by the British Egyptian Business Association (BEBA) on competition law at the Cairo Semiramis Intercontinental Hotel. The theme for the…
Tarek Tawfik, managing director of AmCham Egypt, explains how Egypt’s latest economic reforms have transformed the country into an attractive destination for foreign investors. He highlights the special role of…
Nadia Lamloum, executive director of the British Egyptian Business Association (BEBA), discusses the role of her institution and the investment opportunities that Egypt has to offer, as well as the…
Dr Magdy Abdelhamid, president of the Egyptian Society of Cardiology, explains the main trends in cardiology in Egypt and the society’s prevention projects. He also gives insights into the latest…
Hassan Behnam, managing director of the French Chamber of Commerce and Industry in Egypt explains the investment opportunities Egypt has to offer, examines the close relationship between Egypt and France…
Last week saw the first meeting of the board of Egypt’s new Universal Healthcare Authority (UHA) managed by the Minister of Finance, Mohamed Maait. Created to oversee the implementation of…
Egypt continues to struggle with fake drugs reaching the hands of patients as the suppliers of counterfeit medicines become more sophisticated by adding company logos to packaging. The Egyptian police…
The Health Committee of the Egyptian House of Representatives is preparing to discuss a draft law from the government on the establishment of the “Egyptian Drug Authority.” The new…
Egypt has found a way to profit from the country’s access to cheap Hep C drugs by offering package holidays to tourists suffering from the disease, but the ‘tour and…
With the highest rate of Hepatitis C on the planet, Egypt is now making great efforts to eradicate the disease in the north MENA regions. Hep C is a disease…
As Egypt continues to grapple with the proliferation of the hepatitis C virus, fresh treatment, prevention and market access pathways are now being applied. Given the severity of Egypt’s hepatitis…
See our Cookie Privacy Policy Here
